Compare $BIAF vs $LNAI | Chartloom

Compare

$BIAF vs $LNAI

bioAffinity Technologies Inc · Lunai Bioworks Inc

BIAF

bioAffinity Technologies Inc

LNAI

Lunai Bioworks Inc

Compare $BIAF vs $LNAI

Comparing bioAffinity Technologies Inc and Lunai Bioworks Inc

BIAFbioAffinity Technologies Inc

LNAILunai Bioworks Inc

BIAFbioAffinity Technologies Inc

Market cap

$37M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-23.2%

YTD performance

-74.2%

52W performance

-89.7%

FCF yield

-31.5%

LNAILunai Bioworks Inc

Market cap

$6M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-84.2%

52W performance

-87.6%

FCF yield

-94.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BIAF

LNAI

Detailed metrics comparison

BIAF

bioAffinity Technologies Inc

LNAI

Lunai Bioworks Inc

Market Cap

BIAF$37M

LNAI$6M

Enterprise Value

BIAF$35M

LNAI$3M

Price

BIAF$4.73

LNAI$1.23

P/E Ratio

BIAFN/A

LNAIN/A

P/S Ratio

BIAF6.23x

LNAI266.60x

EV/Sales

BIAF5.93x

LNAI163.08x

EV/EBITDA

BIAF0.00x

LNAI0.00x

P/B Ratio

BIAF1.87x

LNAI0.07x

P/FCF Ratio

BIAFN/A

LNAIN/A

EV/FCF

BIAF-3.02x

LNAI-0.65x

PEG Ratio

BIAFN/A

LNAIN/A

Forward P/E (NTM)

BIAFN/A

LNAIN/A

Forward P/S (NTM)

BIAFN/A

LNAIN/A

Revenue (TTM)

BIAF$6M

LNAI$21K

Revenue Growth (YoY)

BIAF-23.2%

LNAIN/A

Forward Rev Growth

BIAF0.0%

LNAI0.0%

Gross Margin (TTM)

BIAF34.6%

LNAI0.0%

Operating Margin (TTM)

BIAF0.0%

LNAI0.0%

EBITDA Margin (TTM)

BIAF-202.8%

LNAI-46584.2%

Net Margin (TTM)

BIAF-257.3%

LNAI-613799.0%

FCF Margin (TTM)

BIAF-196.0%

LNAI-25165.1%

Net Income (TTM)

BIAF$-15M

LNAI$-128M

FCF (TTM)

BIAF$-12M

LNAI$-5M

EPS (TTM)

BIAF-$43.57

LNAI-$41.06

ROE (TTM)

BIAF-25727.0%

LNAI-6700.0%

ROA (TTM)

BIAF-15954.0%

LNAI-161778.0%

ROIC (TTM)

BIAF-23305.0%

LNAI-6439.0%

Cash

BIAF$2M

LNAI$3M

Debt

BIAF$634K

LNAI$992K

Net Cash/Debt

BIAF$2M

LNAI$2M

Current Ratio (TTM)

BIAF1.44x

LNAI0.19x

Quick Ratio (TTM)

BIAF1.36x

LNAI0.16x

Debt/Equity (TTM)

BIAF0.17x

LNAI0.07x

Debt/Assets (TTM)

BIAF0.0%

LNAI0.0%

Interest Coverage (TTM)

BIAFN/A

LNAIN/A

Net Debt/EBITDA (TTM)

BIAF0.00x

LNAI0.00x

Beta

BIAF-1.26

LNAI0.32

52W Performance

BIAF-89.7%

LNAI-87.6%

YTD Performance

BIAF-74.2%

LNAI-84.2%

% from 52W High

BIAF-94.1%

LNAI-90.7%

% from 52W Low

BIAF3.6%

LNAI40.5%

Asset Turnover (TTM)

BIAF0.62x

LNAI0.00x

FCF Yield (TTM)

BIAF-31.5%

LNAI-94.4%

Earnings Yield (TTM)

BIAF-41.3%

LNAI-2302.3%

Dividend Yield (TTM)

BIAFN/A

LNAIN/A

Rule of 40

BIAF-219.2

LNAI-25,165.1

EV/GP/RG

BIAFN/A

LNAIN/A

Ticker research

View BIAF research View LNAI research

Metric	BIAF bioAffinity Technologies Inc	LNAI Lunai Bioworks Inc
Market & Valuation
Market Cap	$37M	$6M
Enterprise Value	$35M	$3M
Price	$4.73	$1.23
P/E Ratio	N/A	N/A
P/S Ratio	6.23x	266.60x
EV/Sales	5.93x	163.08x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.87x	0.07x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.02x	-0.65x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$6M	$21K
Revenue Growth (YoY)	-23.2%	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	34.6%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-202.8%	-46584.2%
Net Margin (TTM)	-257.3%	-613799.0%
FCF Margin (TTM)	-196.0%	-25165.1%
Net Income (TTM)	$-15M	$-128M
FCF (TTM)	$-12M	$-5M
EPS (TTM)	-$43.57	-$41.06
ROE (TTM)	-25727.0%	-6700.0%
ROA (TTM)	-15954.0%	-161778.0%
ROIC (TTM)	-23305.0%	-6439.0%
Financial Health
Cash	$2M	$3M
Debt	$634K	$992K
Net Cash/Debt	$2M	$2M
Current Ratio (TTM)	1.44x	0.19x
Quick Ratio (TTM)	1.36x	0.16x
Debt/Equity (TTM)	0.17x	0.07x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-1.26	0.32
52W Performance	-89.7%	-87.6%
YTD Performance	-74.2%	-84.2%
% from 52W High	-94.1%	-90.7%
% from 52W Low	3.6%	40.5%
Efficiency & Yields
Asset Turnover (TTM)	0.62x	0.00x
FCF Yield (TTM)	-31.5%	-94.4%
Earnings Yield (TTM)	-41.3%	-2302.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-219.2	-25,165.1
EV/GP/RG	N/A	N/A
Ticker research	View BIAF research	View LNAI research

Valuation

P/S Ratio

BIAF

6.23x

LNAI

266.60x

EV/FCF

BIAF

-3.02x

LNAI

-0.65x

Growth & revenue

Revenue Growth TTM

BIAF

-23.2%

Forward Revenue Growth

BIAF

0.0%

LNAI

0.0%

Profitability & performance

Gross Margin

BIAF

34.6%

LNAI

0.0%

ROE

LNAI

-6700.0%

BIAF

-25727.0%

FCF Yield %

BIAF

-31.5%

LNAI

-94.4%

52-Week Performance

LNAI

-87.6%

BIAF

-89.7%

Detailed metrics comparison

BIAF

bioAffinity Technologies Inc

LNAI

Lunai Bioworks Inc

Market Cap

BIAF$37M

LNAI$6M

Enterprise Value

BIAF$35M

LNAI$3M

Price

BIAF$4.73

LNAI$1.23

P/E Ratio

BIAFN/A

LNAIN/A

P/S Ratio

BIAF6.23x

LNAI266.60x

EV/Sales

BIAF5.93x

LNAI163.08x

EV/EBITDA

BIAF0.00x

LNAI0.00x

P/B Ratio

BIAF1.87x

LNAI0.07x

P/FCF Ratio

BIAFN/A

LNAIN/A

EV/FCF

BIAF-3.02x

LNAI-0.65x

PEG Ratio

BIAFN/A

LNAIN/A

Forward P/E (NTM)

BIAFN/A

LNAIN/A

Forward P/S (NTM)

BIAFN/A

LNAIN/A

Revenue (TTM)

BIAF$6M

LNAI$21K

Revenue Growth (YoY)

BIAF-23.2%

LNAIN/A

Forward Rev Growth

BIAF0.0%

LNAI0.0%

Gross Margin (TTM)

BIAF34.6%

LNAI0.0%

Operating Margin (TTM)

BIAF0.0%

LNAI0.0%

EBITDA Margin (TTM)

BIAF-202.8%

LNAI-46584.2%

Net Margin (TTM)

BIAF-257.3%

LNAI-613799.0%

FCF Margin (TTM)

BIAF-196.0%

LNAI-25165.1%

Net Income (TTM)

BIAF$-15M

LNAI$-128M

FCF (TTM)

BIAF$-12M

LNAI$-5M

EPS (TTM)

BIAF-$43.57

LNAI-$41.06

ROE (TTM)

BIAF-25727.0%

LNAI-6700.0%

ROA (TTM)

BIAF-15954.0%

LNAI-161778.0%

ROIC (TTM)

BIAF-23305.0%

LNAI-6439.0%

Cash

BIAF$2M

LNAI$3M

Debt

BIAF$634K

LNAI$992K

Net Cash/Debt

BIAF$2M

LNAI$2M

Current Ratio (TTM)

BIAF1.44x

LNAI0.19x

Quick Ratio (TTM)

BIAF1.36x

LNAI0.16x

Debt/Equity (TTM)

BIAF0.17x

LNAI0.07x

Debt/Assets (TTM)

BIAF0.0%

LNAI0.0%

Interest Coverage (TTM)

BIAFN/A

LNAIN/A

Net Debt/EBITDA (TTM)

BIAF0.00x

LNAI0.00x

Beta

BIAF-1.26

LNAI0.32

52W Performance

BIAF-89.7%

LNAI-87.6%

YTD Performance

BIAF-74.2%

LNAI-84.2%

% from 52W High

BIAF-94.1%

LNAI-90.7%

% from 52W Low

BIAF3.6%

LNAI40.5%

Asset Turnover (TTM)

BIAF0.62x

LNAI0.00x

FCF Yield (TTM)

BIAF-31.5%

LNAI-94.4%

Earnings Yield (TTM)

BIAF-41.3%

LNAI-2302.3%

Dividend Yield (TTM)

BIAFN/A

LNAIN/A

Rule of 40

BIAF-219.2

LNAI-25,165.1

EV/GP/RG

BIAFN/A

LNAIN/A

Ticker research

View BIAF research View LNAI research

Metric	BIAF bioAffinity Technologies Inc	LNAI Lunai Bioworks Inc
Market & Valuation
Market Cap	$37M	$6M
Enterprise Value	$35M	$3M
Price	$4.73	$1.23
P/E Ratio	N/A	N/A
P/S Ratio	6.23x	266.60x
EV/Sales	5.93x	163.08x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.87x	0.07x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.02x	-0.65x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$6M	$21K
Revenue Growth (YoY)	-23.2%	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	34.6%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-202.8%	-46584.2%
Net Margin (TTM)	-257.3%	-613799.0%
FCF Margin (TTM)	-196.0%	-25165.1%
Net Income (TTM)	$-15M	$-128M
FCF (TTM)	$-12M	$-5M
EPS (TTM)	-$43.57	-$41.06
ROE (TTM)	-25727.0%	-6700.0%
ROA (TTM)	-15954.0%	-161778.0%
ROIC (TTM)	-23305.0%	-6439.0%
Financial Health
Cash	$2M	$3M
Debt	$634K	$992K
Net Cash/Debt	$2M	$2M
Current Ratio (TTM)	1.44x	0.19x
Quick Ratio (TTM)	1.36x	0.16x
Debt/Equity (TTM)	0.17x	0.07x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-1.26	0.32
52W Performance	-89.7%	-87.6%
YTD Performance	-74.2%	-84.2%
% from 52W High	-94.1%	-90.7%
% from 52W Low	3.6%	40.5%
Efficiency & Yields
Asset Turnover (TTM)	0.62x	0.00x
FCF Yield (TTM)	-31.5%	-94.4%
Earnings Yield (TTM)	-41.3%	-2302.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-219.2	-25,165.1
EV/GP/RG	N/A	N/A
Ticker research	View BIAF research	View LNAI research